NCT01866878

Brief Summary

Sensory disorders in patients with multiple sclerosis are among the most common symptoms encountered. A functional impairment based on sensory disorders of the hand. The hand is a sensory organ that transmits the cerebral cortex protopathic sensitive information, proprioceptive or epicritiques. The view-hand association plays an important role in the understanding of the environment. Its exploratory use remains an essential and voluntary basis. The process of recognition of the object passes through manipulation, but operates instantaneously. The brain is able to do a quick summary of the information it receives to determine the nature of the manipulated object. The exploration takes a posteriori, the brain can then determine the details component object (texture, shape, composition, temperature and weight). Neurophysiological mechanisms that would explain the analgesic effects of transcutaneous electrical nerve stimulation (TENS) are not fully understood. Several theories underlying its use as a neuromodulator of pain. The gate control theory has led to the development of TENS devices. Recruitment of myelinated, large caliber, by the TENS electrodes afferent fibers increases the control exerted on spinal level, thereby inhibiting the action of afferent fibers of small caliber related to nociception. This stimulation strengthens the blocking of "gate" at the corresponding cell bodies of spinothalamic tract and reduces the transmission of nociceptive impulses to the spinal cord dorsal horn. This is segmental presynaptic inhibition depends on the area and stimulated. The objective of this study is to improve the quality of life through improved sensitivity disorders of the hand in patients with MS, thanks to reeducation of the hand.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jul 2013

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 3, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

July 30, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2015

Completed
Last Updated

December 2, 2025

Status Verified

March 1, 2018

Enrollment Period

2 years

First QC Date

April 30, 2013

Last Update Submit

November 25, 2025

Conditions

Keywords

transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,Reeducation through labor tactile discrimination

Outcome Measures

Primary Outcomes (1)

  • Compare quality of life between baseline and procedure

    Improve the quality of life through improved sensitivity disorders of the hand in patients with MS, thanks to reeducation of the hand. Unit of mesure: scale MusiQoL

    frist day, 1 month and 3 month

Secondary Outcomes (2)

  • Compare the performance during functional tests between baseline and procedure

    first day, 1 month and 3 month

  • Compare the improvement clinically sensitive target from baseline procedure

    first day, 1 month and 3 month

Study Arms (3)

A group enjoying a corrective touch

EXPERIMENTAL

At first, the patient is asked to gradually define the different types of touch that is applied to the hyposensitive area (fixed or mobile touches) with different textures and then compare them with the healthy side. In a second step, the patient is asked to associate multiple items sensation shape and texture, shape and weight. In a third step is used everyday objects. Desensitisation techniques find their interest mainly when symptoms or dysesthetic hyperesthésique. The objective is to increase the threshold of sensitivity to textures and particles eventually reduce dysaesthetic sensations. The patient class in order of increasing tolerance 10 textures. Dysesthetic area is stimulated 5 to 10 minutes by the first texture to numb the area by saturation of the action potential. This helps promote functional work and recognition of objects. As soon as the texture causes more trouble we go to the next texture by applying the same job.

Device: equipment rehabilitation stereognosis

A group receiving TENS (TENS)

EXPERIMENTAL

Well known in the management of neuropathic pain based on the gate control theory, the application of TENS in the rehabilitation of touch remains to be demonstrated. A recent study applied to the September highlighted the long-term interest of the transcutaneous electrical nerve stimulation (TENS) to improve sensitivity tact arguing possible action on brain plasticity.

Device: TENS

A control group

NO INTERVENTION

Interventions

A group enjoying a corrective touch
TENSDEVICE
A group receiving TENS (TENS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with relapsing remitting MS defined according to Poser criteria \[9\] and McDonald \[5\].
  • Age ≥ 18 years, male or female sex
  • Patients with sensory disorders interesting hands, evidenced by clinical examination objective.
  • Patients with an EDSS between 2 and 4 with functional sensitivity parameter ≥ 2.
  • Patients affiliated to a social security scheme.
  • Patients signed informed consent for the study.

You may not qualify if:

  • Patients with other central or peripheral disorders may affect the sensitivity of the hand.
  • Patients with allodynia in the study area
  • Patients with a motor and / or deficit cerebellar ataxia of the upper limbs.
  • Patients treated with psychotropic or antiepileptic drugs.
  • Patients for whom a flare occurred affecting the sensitivity of the hand, within 30 days before enrollment.
  • Patients holders of an active implantable medical device.
  • Pregnant women and vulnerable patient population.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Pasteur

Nice, 06000, France

Location

MeSH Terms

Conditions

Multiple SclerosisHypersensitivity

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Mikael COHEN, Medical Doctor

    Centre Hospitalier Universitaire de Nice

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2013

First Posted

June 3, 2013

Study Start

July 30, 2013

Primary Completion

July 28, 2015

Study Completion

July 28, 2015

Last Updated

December 2, 2025

Record last verified: 2018-03

Locations